Professor Jeremy Chapman AC – Chair
Clinical Director Division of Medicine and Cancer, Westmead Hospital and Director of Western Renal Services, WSLHD Board Member and Chair WSLHD Research Development Committee.
Jeremy has been involved in development of both the Organ and Bone Marrow Transplant Registry programs in Australia. He is a past president of The Transplantation Society, the World Marrow Donor Association, and The Transplantation Society of Australia and New Zealand.
Jeremy’s current interests involve research and teaching at the University of Sydney and he is Editor in Chief of Transplantation and Transplantation Direct Journals.
Associate Professor Peter Bardy
Associate Professor Peter Bardy trained in Clinical, Laboratory and Research Haematology at the IMVS (1987) and subsequently the Vancouver General Hospital and Terry Fox Laboratories in Vancouver Canada from1992-1995. His first consultant position was as a Clinical Haematologist in the Leukaemia and Bone Marrow Transplantation service at the Royal Melbourne Hospital from 1995 to 1997. Since returning to Adelaide in 1997 he has held positions at ARCBS (Medical Consultant to the Tissue Typing Service) and clinical positions at both the RAH (as a member of the Leukaemia and BMT service) and TQEH (as Head of Clinical and Laboratory Haematology since 2002). Since 2005 he has held leadership roles in the Public Health sector including; Medical Head of the Division of Medicine at TQEH (2006-2008), Chief Medical Officer in the Central Northern Adelaide Health Service (August 2008- July 2010), Chair of the South Australian Clinical Senate (2010 and 2011), Interim Clinical Director Cancer Centre Royal Adelaide Hospital since October 2010 and appointed Clinical Director of Cancer Services in Central Adelaide Local Health Network (CALHN) from 1st November 2012. He also Chairs the State Blood Management Council. His predominant area of clinical expertise is in malignant haematology and bone marrow transplantation.
Brian is a bone marrow donor (donating in 1993) and was a member of the ABMDR’s Ethics Committee. Brian is an engineer by training and a project manager by profession. He is a Churchill Fellow, has been Chairman of the Sydney University International House Council and Chairman of Standards Australia’s Contracts Committee which produced the AS2124/AS4000 suites of contracts. He is a past Managing Director of Capital Insight Pty Ltd.
Sally Gordon worked for the Australian Bone Marrow Donor Registry (ABMDR) since its inception in 1991. Prior to this, her role was in solid organ donation as one of the state donor coordinators for NSW. Whilst at the ABMDR, she was seconded part time to the NSW Department of Health on a project to investigate the possibility of a NSW tissue banking service. Sally has recently retired from her position as Executive Officer of the ABMDR.
Dr Anthony Keller AM
Tony Keller is the current chair of the Donor Centre Advisory Committee of the ABMDR. After qualifying and training in internal medicine in Sydney, he spent seven years in Edinburgh, initially doing research in endocrine immunology and immunodeficiency, and then moving into the transfusion service to continue training in immunohematology and transfusion medicine. He has Fellowships from the Royal Australian College of Physicians and the Royal College of Physicians (Edinburgh) and is a member of the Royal College of Pathologists (London). He was Director of the Hunter Region Blood Transfusion Service in Australia in the early 1980s, and moved to Perth as Director of the Western Australian Blood Transfusion Service in 1984 and continued in this role during the change to the Australian Red Cross Blood Service. Since 2003, he has held the position of National Donor and Product Safety Specialist for the Australian Red Cross Blood Service. He is also an external expert on the Council of Europe’s Committee of Experts on Quality Assurance in Blood Transfusion Services.
Anthony Montague is the National Executive Officer of the ABMDR. Previously, he was the National Cord Blood Network Operations Manager, a role he held for eight years. Anthony’s original training is in engineering, and he has 25 years’ experience in development, quality systems, project management and business management. In the last ten years he has directed his attention to healthcare management, in particular to bone marrow transplantation and the systems for delivering health information. His qualifications include an engineering degree, an MBA and a Master of Public Health.
Professor Jeff Szer AM
Jeff was the foundation Professor/Director of the Department of Clinical Haematology & Bone marrow Transplant Service of the Royal Melbourne Hospital until August 2016 when the Victorian Comprehensive Cancer Centre integration with Peter MacCallum Cancer Centre Haematology service was completed. He continues as a Disease Group Lead in the Parkville Integrated Haematology Service and with his appointment in the University of Melbourne Department of Medicine.
He was the foundation President of the Bone Marrow Transplant Society of Australia and New Zealand and remains a member of the steering committee of the Australasian Bone Marrow Transplant Recipient Registry. He is currently President of the Worldwide Network for Blood and Marrow Transplantation and Chair of the Medical Working Committee of the World Marrow Donor Association. He is a member of the Advisory Committee of the Center for International Blood and Marrow Transplantation.
Jeff is Editor in Chief of the Internal Medicine Journal and a member of editorial boards of Bone Marrow Transplantation, Blood Reviews and BioMed Central. He has published more than 270 papers in the field of marrow transplantation and blood disorders.
In addition to Leonie ‘s role as Non-Executive Director on the ABMDR, Leonie is the President and Chairman of the Fight Cancer Foundation and Co-Chair of the Patient Advisory and Advocacy Committee for the World Network of Blood and Marrow Transplantation.
Leonie Walsh is an experienced leader and adviser in technological innovation with a background that spans more than 30 years of experience both locally and internationally across a diverse range of industries and applications. Leonie continues to focus on strategic science and technology issues including innovation efficiency, technology commercialization, the future skilled workforce and women in science through a range of related boards, advisory and advocacy activities.
More recently Leonie completed a three-year term as Victoria’s inaugural Lead Scientist. In this capacity Leonie was a contributing member on the Future Industries Ministerial Advisory Council, provided contributions to the Education State activities and STEM plan via the Tech Schools STEM Future Industries Advisory Panel and the STEM advisory committee, represented Victoria on the Forum of Australian Chief Scientists and participated on a range of advisory committees and funding assessment panels spanning innovation, education and advanced manufacturing.
Complementary to the Lead Scientists role Leonie Walsh held the honorary role of President of the Australasian Industrial Research Group (AIRG) from 2011 to 2015. In this position Leonie established international collaborations through a new World Federation of Industrial Research Associations and as a partner of the Australian Governments SME to Researcher collaboration (CAESIE) between Australia and the European Union.
Leonie Walsh has received a BSc and an MSc from Swinburne University, an MBA (Exec) from the Australian Graduate School of Management and is a Fellow of the Academy of Technological Sciences and Engineering. In 2014 Leonie received an Honorary Doctorate (HonDUniv) from Swinburne University of Technology for contributions and leadership in scientific enterprises, innovation and the community.